Search filters

List of works by Mark Borris Docdoc Aldonza

Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass

scientific article published on 13 April 2021

Correction: Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells

scientific article published on 21 July 2015

GC-FID determination of cocaine and its metabolites in human bile and vitreous humor

scientific article published in May 2006

Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation

scientific article published on 30 April 2016

Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation

scientific article published on 20 January 2017

Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells.

scientific article published on 12 April 2017

Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms

scientific article published on 07 February 2020

Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.

scientific article

Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells

scientific article published on 22 June 2015

Paulina is supported by:

About Paulina

Help